SubHero Banner

Testosterone Products – New warning

October 25, 2016 – The FDA announced the approval of class-wide labeling changes for all prescription testosterone products, including a new warning and updating the Abuse and Dependence section to include new safety information from published literature and case reports regarding the risks associated with abuse and dependence of testosterone and other anabolic androgenic steroids (AAS).  

Download PDF